Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain
This study has been completed.
Progenics Pharmaceuticals, Inc.
Information provided by:
First received: January 18, 2008
Last updated: July 22, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||May 2008|
|Primary Completion Date:||May 2008 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||March 2, 2009|